Incannex expands IHL-675A indications to include COPD, asthma, bronchitis, and other inflammatory lung conditions – after receiving positive results from additional in vivo studies Feb 4, 2021 ASX News Incannex Healthcare (ASX:IHL) Send Share Share
Incannex Ltd – Entitlement Offer of Loyalty Options Oversubscribed May 30, 2023 | Incannex Healthcare (ASX:IHL)
Incannex – Court Approves Convening of Meetings to Consider Proposed Schemes Oct 4, 2023 | Incannex Healthcare (ASX:IHL)
